{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:17:15Z","timestamp":1788891435869,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00415-025-13209-7","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T16:41:15Z","timestamp":1752856875000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Rituximab in pathologically confirmed sarcoidosis affecting the central nervous system: a multi-center retrospective study"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5644-9638","authenticated-orcid":false,"given":"Spencer K.","family":"Hutto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Balaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachery","family":"Rohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah","family":"Lackey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohini D.","family":"Samudralwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"El Sammak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anudeep","family":"Nakirikanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Oyerinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Bou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Horta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noellie","family":"Rivera Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suma","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharama","family":"Pawate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Tyor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"13209_CR1","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS (2007) Sarcoidosis. N Engl J Med 357:2153\u20132165","journal-title":"N Engl J Med"},{"key":"13209_CR2","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001084","volume":"8","author":"MJ Bradshaw","year":"2021","unstructured":"Bradshaw MJ, Pawate S, Koth LL et al (2021) Neurosarcoidosis: pathophysiology, diagnosis, and treatment. Neurol Neuroimmunol Neuroinflamm 8:e1084","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"13209_CR3","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1001\/jamaneurol.2018.2295","volume":"75","author":"BJ Stern","year":"2018","unstructured":"Stern BJ, Royal W, Gelfand JM et al (2018) Definition and consensus diagnostic criteria for neurosarcoidosis: from the Neurosarcoidosis Consortium Consensus Group. JAMA Neurol 75:1546\u20131553","journal-title":"JAMA Neurol"},{"key":"13209_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/MOH.0000000000000301","volume":"24","author":"P Sakthivel","year":"2017","unstructured":"Sakthivel P, Bruder D (2017) Mechanism of granuloma formation in sarcoidosis. Curr Opin Hematol 24:59\u201365","journal-title":"Curr Opin Hematol"},{"key":"13209_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3389\/fimmu.2013.00437","volume":"4","author":"CE Broos","year":"2013","unstructured":"Broos CE, van Nimwegen M, Hoogsteden HC et al (2013) Granuloma formation in pulmonary sarcoidosis. Front Immunol 4:437","journal-title":"Front Immunol"},{"issue":"20","key":"13209_CR6","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1212\/WNL.0000000000004644","volume":"89","author":"JM Gelfand","year":"2017","unstructured":"Gelfand JM, Bradshaw MJ, Stern BJ et al (2017) Infliximab for the treatment of CNS sarcoidosis: a multi-institutional series. Neurology 89(20):2092\u20132100","journal-title":"Neurology"},{"issue":"5","key":"13209_CR7","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000847","volume":"7","author":"D Fritz","year":"2020","unstructured":"Fritz D, Timmermans WMC, van Laar JAM et al (2020) Infliximab treatment in pathology-confirmed neurosarcoidosis. Neurol Neuroimmunol Neuroinflamm 7(5):e847","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"13209_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/00002281-200001000-00012","volume":"12","author":"C Agostini","year":"2000","unstructured":"Agostini C, Adami F, Semenzato G (2000) New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol 12:71\u201376","journal-title":"Curr Opin Rheumatol"},{"key":"13209_CR9","unstructured":"Giovannoni G, Chamoun V, Scadding J, et al (2012) Neurosarcoidosis. Sarcoidosis. 256\u2013270."},{"issue":"3","key":"13209_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/practneurol-2019-002349","volume":"20","author":"DP Kidd","year":"2020","unstructured":"Kidd DP (2020) Neurosarcoidosis: clinical manifestations, investigation and treatment. Pract Neurol 20(3):199\u2013212","journal-title":"Pract Neurol"},{"issue":"3","key":"13209_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1212\/CON.0000000000000855","volume":"26","author":"S Pawate","year":"2020","unstructured":"Pawate S (2020) Sarcoidosis and the nervous system. Continuum 26(3):695\u2013715","journal-title":"Continuum"},{"key":"13209_CR12","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1183\/09031936.00019114","volume":"43","author":"MK Nakhleh","year":"2014","unstructured":"Nakhleh MK, Jeries R, Gharra A et al (2014) Detecting active pulmonary tuberculosis with a breath test using nanomaterial-based sensors. Eur Respir J 43:1522\u20131525","journal-title":"Eur Respir J"},{"issue":"2","key":"13209_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cardfail.2021.07.008","volume":"28","author":"M Elwazir","year":"2022","unstructured":"Elwazir M, Krause ML, Bois JP et al (2022) Rituximab for the treatment of refractory cardiac sarcoidosis: a single-center experience. J Card Fail 28(2):247\u2013258","journal-title":"J Card Fail"},{"issue":"6","key":"13209_CR14","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1097\/RHU.0000000000000900","volume":"25","author":"B Earle","year":"2019","unstructured":"Earle B, Wolf DS, Ramsay ES (2019) Novel use of rituximab in treatment of refractory neurosarcoidosis in an 11-year-old girl. J Clin Rheumatol 25(6):e101-103","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"13209_CR15","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1212\/WNL.0b013e3181ec7ff9","volume":"75","author":"R Bomprezzi","year":"2010","unstructured":"Bomprezzi R, Pati S, Chansakul C et al (2010) A case of neurosarcoidosis successfully treated with rituximab. Neurology 75(6):568\u2013570","journal-title":"Neurology"},{"key":"13209_CR16","doi-asserted-by":"publisher","first-page":"175628641880573","DOI":"10.1177\/1756286418805732","volume":"11","author":"S Zella","year":"2018","unstructured":"Zella S, Kneiphof J, Haghikia A et al (2018) Successful therapy with rituximab in three patients with probable neurosarcoidosis. Ther Adv Neurol Disord 11:1756286418805732","journal-title":"Ther Adv Neurol Disord"},{"key":"13209_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s40674-017-0082-y","volume":"3","author":"C King","year":"2017","unstructured":"King C, Harper L (2017) Avoidance of harm from treatment for ANCA-associated vasculitis. Curr Treatm Opt Rheumatol 3:230\u2013343","journal-title":"Curr Treatm Opt Rheumatol"},{"issue":"3","key":"13209_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R et al (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363(3):221\u2013232","journal-title":"N Engl J Med"},{"key":"13209_CR19","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1136\/ard.2008.092163","volume":"68","author":"D Huscher","year":"2009","unstructured":"Huscher D, Thiele K, Gromnica-Ihle E et al (2009) Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 68:1119\u20131124","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"13209_CR20","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/archneur.1995.00540330053014","volume":"52","author":"BN Agbogu","year":"1995","unstructured":"Agbogu BN, Stern BJ, Sewell C et al (1995) Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 52(9):875\u2013879","journal-title":"Arch Neurol"},{"issue":"1","key":"13209_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","volume":"4","author":"FA Bonilla","year":"2016","unstructured":"Bonilla FA, Barlan I, Chapel H et al (2016) International consensus cocument (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract 4(1):38\u201359","journal-title":"J Allergy Clin Immunol Pract"},{"key":"13209_CR22","doi-asserted-by":"publisher","first-page":"123018","DOI":"10.1016\/j.jns.2024.123018","volume":"460","author":"J Shen","year":"2024","unstructured":"Shen J, Sugita M, Linares-Lopez A et al (2024) Adalimumab as treatment for neurosarcoidosis: a case series. J Neurol Sci 460:123018","journal-title":"J Neurol Sci"},{"key":"13209_CR23","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1007\/s00415-021-10793-2","volume":"269","author":"SK Hutto","year":"2022","unstructured":"Hutto SK, Kyle K, Cavanagh JJ et al (2022) Adalimumab for CNS sarcoidosis: single-center experience and literature review. J Neurol 269:2064\u20132072","journal-title":"J Neurol"},{"issue":"24","key":"13209_CR24","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1212\/WNL.0000000000003431","volume":"87","author":"S Bitoun","year":"2016","unstructured":"Bitoun S, Bouvry D, Borie R et al (2016) Treatment of neurosarcoidosis: a comparative study of methotrexate and mycophenolate mofetil. Neurology 87(24):2517\u20132521","journal-title":"Neurology"},{"key":"13209_CR25","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1001\/jamaneurol.2017.2492","volume":"74","author":"B Joubert","year":"2017","unstructured":"Joubert B, Chapelon-Abric C, Biard L et al (2017) Association of prognostic factors and immunosuppressive treatment with long-term outcomes in neurosarcoidosis. JAMA Neurol 74:1336\u20131344","journal-title":"JAMA Neurol"},{"key":"13209_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.mayocp.2015.10.024","volume":"91","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert P, Carmona EM, Utz JP et al (2016) Epidemiology of sarcoidosis 1946\u20132013: a population-based Study. Mayo Clin Proc 91:183\u2013188","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"13209_CR27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/0002-9343(74)90160-0","volume":"57","author":"LE Siltzbach","year":"1974","unstructured":"Siltzbach LE, James DG, Neville E et al (1974) Course and prognosis of sarcoidosis around the world. Am J Med 57(6):847\u2013852","journal-title":"Am J Med"},{"issue":"2","key":"13209_CR28","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200429","volume":"15","author":"GS Manzano","year":"2025","unstructured":"Manzano GS, Eaton J, Levy M et al (2025) Consensus recommendations for the management of neurosarcoidosis. Neurol Clin Pract 15(2):e200429","journal-title":"Neurol Clin Pract"},{"issue":"12","key":"13209_CR29","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1001\/jamaneurol.2024.3524","volume":"81","author":"W Xie","year":"2024","unstructured":"Xie W, Sun Y, Zhang W et al (2024) Risk of inflammatory central nervous system diseases after tumor necrosis factor-inhibitor treatment for autoimmune diseases: a systematic review and meta-analysis. JAMA Neurol 81(12):1284\u20131294","journal-title":"JAMA Neurol"},{"key":"13209_CR30","doi-asserted-by":"publisher","first-page":"577587","DOI":"10.1016\/j.jneuroim.2021.577587","volume":"356","author":"SK Hutto","year":"2021","unstructured":"Hutto SK, Rice DR, Mateen FJ (2021) CNS demyelination with TNF\u03b1 inhibitor exposure: a retrospective cohort study. J Neuroimmunol 356:577587","journal-title":"J Neuroimmunol"},{"key":"13209_CR31","doi-asserted-by":"publisher","first-page":"117282","DOI":"10.1016\/j.jns.2020.117282","volume":"420","author":"LM Webb","year":"2021","unstructured":"Webb LM, Chen JJ, Aksamit AJ et al (2021) A multi-center case series of sarcoid optic neuropathy. J Neurol Sci 420:117282","journal-title":"J Neurol Sci"},{"issue":"4","key":"13209_CR32","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001170","volume":"9","author":"GA Bou","year":"2022","unstructured":"Bou GA, Garcia-Santibanez R, Castilho AJ et al (2022) Neurosarcoidosis of the cauda equina: clinical course, radiographic and electrodiagnostic findings, response to treatment, and outcomes. Neurol Neuroimmunol Neuroinflamm 9(4):e1170","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"13209_CR33","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1093\/rheumatology\/keac608","volume":"62","author":"C Wincup","year":"2023","unstructured":"Wincup C, Dunn N, Ruetsch-Chelli C et al (2023) Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus. Rheumatology 62:2601\u20132610","journal-title":"Rheumatology"},{"key":"13209_CR34","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.3389\/fimmu.2019.03069","volume":"10","author":"S Boyer-Suavet","year":"2020","unstructured":"Boyer-Suavet S, Andreani M, Lateb M et al (2020) Neutralizing anti-rituximab antibodies and relapse in membranous nephropathy treated with rituximab. Front Immunol 10:3069","journal-title":"Front Immunol"},{"key":"13209_CR35","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1177\/1352458517720044","volume":"24","author":"N Dunn","year":"2018","unstructured":"Dunn N, Juto A, Ryner M et al (2018) Rituximab in multiple sclerosis: frequency and clinical relevance of anti-drug antibodies. Mult Scler 24:1224\u20131233","journal-title":"Mult Scler"},{"key":"13209_CR36","doi-asserted-by":"publisher","first-page":"104587","DOI":"10.1016\/j.msard.2023.104587","volume":"71","author":"E Lackey","year":"2023","unstructured":"Lackey E, Shen J, Veal K et al (2023) Steroid-induced weight gain in the treatment of neurosarcoidosis. Mult Scler Relat Disord 71:104587","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"13209_CR37","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/archneur.64.5.691","volume":"64","author":"TF Scott","year":"2007","unstructured":"Scott TF, Yandora K, Valeri A et al (2007) Aggressive therapy for neurosarcoidosis: long-term follow-up of 48 treated patients. Arch Neurol 64(5):691\u2013696","journal-title":"Arch Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13209-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13209-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13209-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:23:50Z","timestamp":1757255030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13209-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["13209"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13209-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S. K. Hutto reports no disclosures; D. T. Balaban reports that his institution receives support from ArgenX for an investigator-initiated clinical trial; Z. Rohm reports no disclosures; E. Lackey reports no disclosures; R. D. Samudralwar reports no disclosures; S. El Sammak reports no disclosures; A. Nakirikanti reports no disclosures; E. Oyerinde reports no disclosures; G. Bou reports no disclosures; M. Herman reports no disclosures; L. Horta reports no disclosures; M. Taha reports no disclosures; N. Rivera Torres reports no disclosures; A. Morrison reports no disclosures; S. Shah has received honoraria from Novartis and TGTherapeutics for participation in advisory boards and consulting, respectively; S. Pawate reports no disclosures; D. Vargas reports no disclosures; W. Tyor reports no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Utilizing a shared study protocol, local institutional review boards for each participating center approved this retrospective study with complete waivers of consent granted in view of its retrospective nature and all procedures being previously performed as a manner of routine care. Upon request by qualified investigators, anonymized data will be made available as subject to ethics board approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}],"article-number":"519"}}